Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single Agent Chemotherapy With Weekly Docetaxel vs Combination Chemotherapy in Second-line Treatment of Advanced Non Small Cell Lung Cancer

NCT00345059 is registered in ClinicalTrials.gov with National Cancer Institute, Naples as lead sponsor.

NCT NCT00345059
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00345059 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single Agent Chemotherapy With Weekly Docetaxel vs Combination Chemotherapy in Second-line Treatment of Advanced Non Small Cell Lung Cancer
Lead sponsor
National Cancer Institute, Naples
Phase
Phase 3
Overall status
Terminated
Start date
May 31, 2005
Completion date
May 31, 2008
Enrollment
84 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

advanced non-small cell lung cancer